Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2011

Open Access 01-12-2011 | Research article

Estrogenic botanical supplements, health-related quality of life, fatigue, and hormone-related symptoms in breast cancer survivors: a HEAL study report

Authors: Huiyan Ma, Jane Sullivan-Halley, Ashley W Smith, Marian L Neuhouser, Catherine M Alfano, Kathleen Meeske, Stephanie M George, Anne McTiernan, Roberta McKean-Cowdin, Kathy B Baumgartner, Rachel Ballard-Barbash, Leslie Bernstein

Published in: BMC Complementary Medicine and Therapies | Issue 1/2011

Login to get access

Abstract

Background

It remains unclear whether estrogenic botanical supplement (EBS) use influences breast cancer survivors' health-related outcomes.

Methods

We examined the associations of EBS use with health-related quality of life (HRQOL), with fatigue, and with 15 hormone-related symptoms such as hot flashes and night sweats among 767 breast cancer survivors participating in the Health, Eating, Activity, and Lifestyle (HEAL) Study. HRQOL was measured by the Medical Outcomes Study short form-36 physical and mental component scale summary score. Fatigue was measured by the Revised-Piper Fatigue Scale score.

Results

Neither overall EBS use nor the number of EBS types used was associated with HRQOL, fatigue, or hormone-related symptoms. However, comparisons of those using each specific type of EBS with non-EBS users revealed the following associations. Soy supplements users were more likely to have a better physical health summary score (odds ratio [OR] = 1.66, 95% confidence interval [CI] = 1.02-2.70). Flaxseed oil users were more likely to have a better mental health summary score (OR = 1.76, 95% CI = 1.05-2.94). Ginseng users were more likely to report severe fatigue and several hormone-related symptoms (all ORs ≥ 1.7 and all 95% CIs exclude 1). Red clover users were less likely to report weight gain, night sweats, and difficulty concentrating (all OR approximately 0.4 and all 95% CIs exclude 1). Alfalfa users were less likely to experience sleep interruption (OR = 0.28, 95% CI = 0.12-0.68). Dehydroepiandrosterone users were less likely to have hot flashes (OR = 0.33, 95% CI = 0.14-0.82).

Conclusions

Our findings indicate that several specific types of EBS might have important influences on a woman's various aspects of quality of life, but further verification is necessary.
Literature
1.
go back to reference Boon H, Stewart M, Kennard MA, Gray R, Sawka C, Brown JB, McWilliam C, Gavin A, Baron RA, Aaron D, Haines-Kamka T: Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol. 2000, 18: 2515-2521.PubMed Boon H, Stewart M, Kennard MA, Gray R, Sawka C, Brown JB, McWilliam C, Gavin A, Baron RA, Aaron D, Haines-Kamka T: Use of complementary/alternative medicine by breast cancer survivors in Ontario: prevalence and perceptions. J Clin Oncol. 2000, 18: 2515-2521.PubMed
2.
go back to reference Nahleh Z, Tabbara IA: Complementary and alternative medicine in breast cancer patients. Palliat Support Care. 2003, 1: 267-273.CrossRefPubMed Nahleh Z, Tabbara IA: Complementary and alternative medicine in breast cancer patients. Palliat Support Care. 2003, 1: 267-273.CrossRefPubMed
3.
go back to reference Food and drug administration: Food and drug administration. Dietary Supplement Health and Education Act of 1994. cited 2010 Aug 16 Food and drug administration: Food and drug administration. Dietary Supplement Health and Education Act of 1994. cited 2010 Aug 16
4.
go back to reference Kirk CJ, Harris RM, Wood DM, Waring RH, Hughes PJ: Do dietary phytoestrogens influence susceptibility to hormone-dependent cancer by disrupting the metabolism of endogenous oestrogens?. Biochem Soc Trans. 2001, 29: 209-216. 10.1042/BST0290209.CrossRefPubMed Kirk CJ, Harris RM, Wood DM, Waring RH, Hughes PJ: Do dietary phytoestrogens influence susceptibility to hormone-dependent cancer by disrupting the metabolism of endogenous oestrogens?. Biochem Soc Trans. 2001, 29: 209-216. 10.1042/BST0290209.CrossRefPubMed
5.
go back to reference Moutsatsou P: The spectrum of phytoestrogens in nature: our knowledge is expanding. Hormones (Athens). 2007, 6: 173-193. Moutsatsou P: The spectrum of phytoestrogens in nature: our knowledge is expanding. Hormones (Athens). 2007, 6: 173-193.
6.
go back to reference Henderson BE, Ross RK, Pike MC, Casagrande JT: Endogenous hormones as a major factor in human cancer. Cancer Res. 1982, 42: 3232-3239.PubMed Henderson BE, Ross RK, Pike MC, Casagrande JT: Endogenous hormones as a major factor in human cancer. Cancer Res. 1982, 42: 3232-3239.PubMed
7.
go back to reference Bernstein L, Ross RK: Endogenous hormones and breast cancer risk. Epidemiol Rev. 1993, 15: 48-65.PubMed Bernstein L, Ross RK: Endogenous hormones and breast cancer risk. Epidemiol Rev. 1993, 15: 48-65.PubMed
8.
go back to reference Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, Stanczyk FZ, Stephenson HE, Falk RT, Miller R: Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst. 2003, 95: 1218-1226.CrossRefPubMed Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, Stanczyk FZ, Stephenson HE, Falk RT, Miller R: Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst. 2003, 95: 1218-1226.CrossRefPubMed
9.
go back to reference Burstein HJ, Prestrud AA, Seidenfeld J, Anderson H, Buchholz TA, Davidson NE, Gelmon KE, Giordano SH, Hudis CA, Malin J: American society of clinical oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol. 2010, 28: 3784-3796. 10.1200/JCO.2009.26.3756.CrossRefPubMed Burstein HJ, Prestrud AA, Seidenfeld J, Anderson H, Buchholz TA, Davidson NE, Gelmon KE, Giordano SH, Hudis CA, Malin J: American society of clinical oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol. 2010, 28: 3784-3796. 10.1200/JCO.2009.26.3756.CrossRefPubMed
10.
go back to reference Wu WH, Liu LY, Chung CJ, Jou HJ, Wang TA: Estrogenic effect of yam ingestion in healthy postmenopausal women. J Am Coll Nutr. 2005, 24: 235-243.CrossRefPubMed Wu WH, Liu LY, Chung CJ, Jou HJ, Wang TA: Estrogenic effect of yam ingestion in healthy postmenopausal women. J Am Coll Nutr. 2005, 24: 235-243.CrossRefPubMed
11.
go back to reference Wu AH, Stanczyk FZ, Martinez C, Tseng CC, Hendrich S, Murphy P, Chaikittisilpa S, Stram DO, Pike MC: A controlled 2-mo dietary fat reduction and soy food supplementation study in postmenopausal women. Am J Clin Nutr. 2005, 81: 1133-1141.PubMed Wu AH, Stanczyk FZ, Martinez C, Tseng CC, Hendrich S, Murphy P, Chaikittisilpa S, Stram DO, Pike MC: A controlled 2-mo dietary fat reduction and soy food supplementation study in postmenopausal women. Am J Clin Nutr. 2005, 81: 1133-1141.PubMed
12.
go back to reference Low YL, Taylor JI, Grace PB, Dowsett M, Scollen S, Dunning AM, Mulligan AA, Welch AA, Luben RN, Khaw KT: Phytoestrogen exposure correlation with plasma estradiol in postmenopausal women in European Prospective Investigation of Cancer and Nutrition-Norfolk may involve diet-gene interactions. Cancer Epidemiol Biomarkers Prev. 2005, 14: 213-220.PubMed Low YL, Taylor JI, Grace PB, Dowsett M, Scollen S, Dunning AM, Mulligan AA, Welch AA, Luben RN, Khaw KT: Phytoestrogen exposure correlation with plasma estradiol in postmenopausal women in European Prospective Investigation of Cancer and Nutrition-Norfolk may involve diet-gene interactions. Cancer Epidemiol Biomarkers Prev. 2005, 14: 213-220.PubMed
13.
go back to reference Wayne SJ, Neuhouser ML, Koprowski C, Ulrich CM, Wiggins C, Gilliland F, Baumgartner KB, Baumgartner RN, McTiernan A, Bernstein L, Ballard-Barbash R: Breast cancer survivors who use estrogenic botanical supplements have lower serum estrogen levels than non users. Breast Cancer Res Treat. 2009, 117: 111-119. 10.1007/s10549-008-0224-x.CrossRefPubMed Wayne SJ, Neuhouser ML, Koprowski C, Ulrich CM, Wiggins C, Gilliland F, Baumgartner KB, Baumgartner RN, McTiernan A, Bernstein L, Ballard-Barbash R: Breast cancer survivors who use estrogenic botanical supplements have lower serum estrogen levels than non users. Breast Cancer Res Treat. 2009, 117: 111-119. 10.1007/s10549-008-0224-x.CrossRefPubMed
14.
go back to reference Burstein HJ, Gelber S, Guadagnoli E, Weeks JC: Use of alternative medicine by women with early-stage breast cancer. N Engl J Med. 1999, 340: 1733-1739. 10.1056/NEJM199906033402206.CrossRefPubMed Burstein HJ, Gelber S, Guadagnoli E, Weeks JC: Use of alternative medicine by women with early-stage breast cancer. N Engl J Med. 1999, 340: 1733-1739. 10.1056/NEJM199906033402206.CrossRefPubMed
15.
go back to reference Carpenter CL, Ganz PA, Bernstein L: Complementary and alternative therapies among very long-term breast cancer survivors. Breast Cancer Res Treat. 2009, 116: 387-396. 10.1007/s10549-008-0158-3.CrossRefPubMed Carpenter CL, Ganz PA, Bernstein L: Complementary and alternative therapies among very long-term breast cancer survivors. Breast Cancer Res Treat. 2009, 116: 387-396. 10.1007/s10549-008-0158-3.CrossRefPubMed
16.
go back to reference Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR: Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst. 2002, 94: 39-49. 10.1093/jnci/94.1.39.CrossRefPubMed Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR: Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst. 2002, 94: 39-49. 10.1093/jnci/94.1.39.CrossRefPubMed
17.
go back to reference Buettner C, Kroenke CH, Phillips RS, Davis RB, Eisenberg DM, Holmes MD: Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses' health study. Breast Cancer Res Treat. 2006, 100: 219-227. 10.1007/s10549-006-9239-3.CrossRefPubMed Buettner C, Kroenke CH, Phillips RS, Davis RB, Eisenberg DM, Holmes MD: Correlates of use of different types of complementary and alternative medicine by breast cancer survivors in the nurses' health study. Breast Cancer Res Treat. 2006, 100: 219-227. 10.1007/s10549-006-9239-3.CrossRefPubMed
18.
go back to reference Ma H, Carpenter CL, Sullivan-Halley J, Bernstein L: The roles of herbal remedies in survival and quality of life among long-term breast cancer survivors - results of a prospective study. BMC Cancer. 2011, 11: 222-10.1186/1471-2407-11-222.CrossRefPubMedPubMedCentral Ma H, Carpenter CL, Sullivan-Halley J, Bernstein L: The roles of herbal remedies in survival and quality of life among long-term breast cancer survivors - results of a prospective study. BMC Cancer. 2011, 11: 222-10.1186/1471-2407-11-222.CrossRefPubMedPubMedCentral
19.
go back to reference Ganz PA, Day R, Ware JE, Redmond C, Fisher B: Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. J Natl Cancer Inst. 1995, 87: 1372-1382. 10.1093/jnci/87.18.1372.CrossRefPubMed Ganz PA, Day R, Ware JE, Redmond C, Fisher B: Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. J Natl Cancer Inst. 1995, 87: 1372-1382. 10.1093/jnci/87.18.1372.CrossRefPubMed
20.
go back to reference Irwin ML, McTiernan A, Bernstein L, Gilliland FD, Baumgartner R, Baumgartner K, Ballard-Barbash R: Physical activity levels among breast cancer survivors. Med Sci Sports Exerc. 2004, 36: 1484-1491.PubMedPubMedCentral Irwin ML, McTiernan A, Bernstein L, Gilliland FD, Baumgartner R, Baumgartner K, Ballard-Barbash R: Physical activity levels among breast cancer survivors. Med Sci Sports Exerc. 2004, 36: 1484-1491.PubMedPubMedCentral
21.
go back to reference McTiernan A, Rajan KB, Tworoger SS, Irwin M, Bernstein L, Baumgartner R, Gilliland F, Stanczyk FZ, Yasui Y, Ballard-Barbash R: Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol. 2003, 21: 1961-1966. 10.1200/JCO.2003.07.057.CrossRefPubMedPubMedCentral McTiernan A, Rajan KB, Tworoger SS, Irwin M, Bernstein L, Baumgartner R, Gilliland F, Stanczyk FZ, Yasui Y, Ballard-Barbash R: Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol. 2003, 21: 1961-1966. 10.1200/JCO.2003.07.057.CrossRefPubMedPubMedCentral
22.
go back to reference Gruendwald J, Brendler T, Jaenicke C: Physician's Desk Reference for Herbal Products. 2007, Montvale: Thompson Healthcare, 4 Gruendwald J, Brendler T, Jaenicke C: Physician's Desk Reference for Herbal Products. 2007, Montvale: Thompson Healthcare, 4
23.
go back to reference Cassileth BR, Lucarelli CD: Herb-drug interactions in oncology. 2003, New York: BC Decker Inc. Cassileth BR, Lucarelli CD: Herb-drug interactions in oncology. 2003, New York: BC Decker Inc.
24.
go back to reference Jellin JM, Gregory PJ: Natural medicine comprehensive database. 2007 Jellin JM, Gregory PJ: Natural medicine comprehensive database. 2007
25.
go back to reference Kriska A: Modifiable Activity Questionnaire for Adolescents. Medicine Science in Sports Exercise. 1997, 29: 79-82. Kriska A: Modifiable Activity Questionnaire for Adolescents. Medicine Science in Sports Exercise. 1997, 29: 79-82.
26.
go back to reference Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, O'Brien WL, Bassett DR, Schmitz KH, Emplaincourt PO: Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000, 32: S498-504. 10.1097/00005768-200009001-00009.CrossRefPubMed Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, O'Brien WL, Bassett DR, Schmitz KH, Emplaincourt PO: Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000, 32: S498-504. 10.1097/00005768-200009001-00009.CrossRefPubMed
27.
go back to reference Irwin ML, Smith AW, McTiernan A, Ballard-Barbash R, Cronin K, Gilliland FD, Baumgartner RN, Baumgartner KB, Bernstein L: Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study. J Clin Oncol. 2008, 26: 3958-3964. 10.1200/JCO.2007.15.9822.CrossRefPubMedPubMedCentral Irwin ML, Smith AW, McTiernan A, Ballard-Barbash R, Cronin K, Gilliland FD, Baumgartner RN, Baumgartner KB, Bernstein L: Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study. J Clin Oncol. 2008, 26: 3958-3964. 10.1200/JCO.2007.15.9822.CrossRefPubMedPubMedCentral
28.
go back to reference Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs-Collins T: Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol. 1999, 9: 178-187. 10.1016/S1047-2797(98)00055-6.CrossRefPubMed Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs-Collins T: Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol. 1999, 9: 178-187. 10.1016/S1047-2797(98)00055-6.CrossRefPubMed
29.
go back to reference Hays RD, Sherbourne CD, Mazel RM: The RAND 36-Item Health Survey 1.0. Health Econ. 1993, 2: 217-227. 10.1002/hec.4730020305.CrossRefPubMed Hays RD, Sherbourne CD, Mazel RM: The RAND 36-Item Health Survey 1.0. Health Econ. 1993, 2: 217-227. 10.1002/hec.4730020305.CrossRefPubMed
30.
go back to reference Ware JE: SF-36 Physical and Mental Health Summary Scales: a user's manual. 1994, Boston: The Health Institute, Second Ware JE: SF-36 Physical and Mental Health Summary Scales: a user's manual. 1994, Boston: The Health Institute, Second
31.
go back to reference Ware JE, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A: Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care. 1995, 33: AS264-279.CrossRefPubMed Ware JE, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A: Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care. 1995, 33: AS264-279.CrossRefPubMed
32.
go back to reference Ware JE: SF-36 physical & mental health summary scales: a manual for users of version 1. 2001, Lincoln, RI: QualityMetric Incorporated, Second Ware JE: SF-36 physical & mental health summary scales: a manual for users of version 1. 2001, Lincoln, RI: QualityMetric Incorporated, Second
33.
go back to reference Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM: The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum. 1998, 25: 677-684.PubMed Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM: The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum. 1998, 25: 677-684.PubMed
34.
go back to reference Meeske KA, Siegel SE, Globe DR, Mack WJ, Bernstein L: Prevalence and correlates of fatigue in long-term survivors of childhood leukemia. J Clin Oncol. 2005, 23: 5501-5510. 10.1200/JCO.2005.03.210.CrossRefPubMed Meeske KA, Siegel SE, Globe DR, Mack WJ, Bernstein L: Prevalence and correlates of fatigue in long-term survivors of childhood leukemia. J Clin Oncol. 2005, 23: 5501-5510. 10.1200/JCO.2005.03.210.CrossRefPubMed
35.
go back to reference Berger AM: Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncol Nurs Forum. 1998, 25: 51-62.PubMed Berger AM: Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncol Nurs Forum. 1998, 25: 51-62.PubMed
36.
go back to reference Woo B, Dibble SL, Piper BF, Keating SB, Weiss MC: Differences in fatigue by treatment methods in women with breast cancer. Oncol Nurs Forum. 1998, 25: 915-920.PubMed Woo B, Dibble SL, Piper BF, Keating SB, Weiss MC: Differences in fatigue by treatment methods in women with breast cancer. Oncol Nurs Forum. 1998, 25: 915-920.PubMed
37.
go back to reference Wu HS, McSweeney M: Measurement of fatigue in people with cancer. Oncol Nurs Forum. 2001, 28: 1371-1384. quiz 1385-1376PubMed Wu HS, McSweeney M: Measurement of fatigue in people with cancer. Oncol Nurs Forum. 2001, 28: 1371-1384. quiz 1385-1376PubMed
38.
go back to reference Alfano CM, McGregor BA, Kuniyuki A, Reeve BB, Bowen DJ, Baumgartner KB, Bernstein L, Ballard-Barbash R, Malone KE, Ganz PA, McTiernan A: Psychometric properties of a tool for measuring hormone-related symptoms in breast cancer survivors. Psychooncology. 2006, 15: 985-1000. 10.1002/pon.1033.CrossRefPubMedPubMedCentral Alfano CM, McGregor BA, Kuniyuki A, Reeve BB, Bowen DJ, Baumgartner KB, Bernstein L, Ballard-Barbash R, Malone KE, Ganz PA, McTiernan A: Psychometric properties of a tool for measuring hormone-related symptoms in breast cancer survivors. Psychooncology. 2006, 15: 985-1000. 10.1002/pon.1033.CrossRefPubMedPubMedCentral
39.
go back to reference Lee C, Powers JR: Number of social roles, health, and well-being in three generations of Australian women. Int J Behav Med. 2002, 9: 195-215. 10.1207/S15327558IJBM0903_03.CrossRefPubMed Lee C, Powers JR: Number of social roles, health, and well-being in three generations of Australian women. Int J Behav Med. 2002, 9: 195-215. 10.1207/S15327558IJBM0903_03.CrossRefPubMed
40.
go back to reference Islam S, Carter K, Mhurchu CN, Anderson CS: Selenium and zinc in hair and toenails in relation to the physical and mental health status of older adults: The Freemasons Health study in New Zealand. Australasian Journal on Ageing. 2007, 26: 180-186. 10.1111/j.1741-6612.2007.00252.x.CrossRef Islam S, Carter K, Mhurchu CN, Anderson CS: Selenium and zinc in hair and toenails in relation to the physical and mental health status of older adults: The Freemasons Health study in New Zealand. Australasian Journal on Ageing. 2007, 26: 180-186. 10.1111/j.1741-6612.2007.00252.x.CrossRef
41.
go back to reference Meeske K, Smith AW, Alfano CM, McGregor BA, McTiernan A, Baumgartner KB, Malone KE, Reeve BB, Ballard-Barbash R, Bernstein L: Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL Study report. Qual Life Res. 2007, 16: 947-960. 10.1007/s11136-007-9215-3.CrossRefPubMed Meeske K, Smith AW, Alfano CM, McGregor BA, McTiernan A, Baumgartner KB, Malone KE, Reeve BB, Ballard-Barbash R, Bernstein L: Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL Study report. Qual Life Res. 2007, 16: 947-960. 10.1007/s11136-007-9215-3.CrossRefPubMed
42.
go back to reference Bender R, Lange S: Adjusting for multiple testing--when and how?. J Clin Epidemiol. 2001, 54: 343-349. 10.1016/S0895-4356(00)00314-0.CrossRefPubMed Bender R, Lange S: Adjusting for multiple testing--when and how?. J Clin Epidemiol. 2001, 54: 343-349. 10.1016/S0895-4356(00)00314-0.CrossRefPubMed
43.
go back to reference Kostelac D, Rechkemmer G, Briviba K: Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element. J Agric Food Chem. 2003, 51: 7632-7635. 10.1021/jf034427b.CrossRefPubMed Kostelac D, Rechkemmer G, Briviba K: Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element. J Agric Food Chem. 2003, 51: 7632-7635. 10.1021/jf034427b.CrossRefPubMed
44.
go back to reference Hwang CS, Kwak HS, Lim HJ, Lee SH, Kang YS, Choe TB, Hur HG, Han KO: Isoflavone metabolites and their in vitro dual functions: they can act as an estrogenic agonist or antagonist depending on the estrogen concentration. J Steroid Biochem Mol Biol. 2006, 101: 246-253. 10.1016/j.jsbmb.2006.06.020.CrossRefPubMed Hwang CS, Kwak HS, Lim HJ, Lee SH, Kang YS, Choe TB, Hur HG, Han KO: Isoflavone metabolites and their in vitro dual functions: they can act as an estrogenic agonist or antagonist depending on the estrogen concentration. J Steroid Biochem Mol Biol. 2006, 101: 246-253. 10.1016/j.jsbmb.2006.06.020.CrossRefPubMed
45.
go back to reference Quella SK, Loprinzi CL, Barton DL, Knost JA, Sloan JA, LaVasseur BI, Swan D, Krupp KR, Miller KD, Novotny PJ: Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial. J Clin Oncol. 2000, 18: 1068-1074.PubMed Quella SK, Loprinzi CL, Barton DL, Knost JA, Sloan JA, LaVasseur BI, Swan D, Krupp KR, Miller KD, Novotny PJ: Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial. J Clin Oncol. 2000, 18: 1068-1074.PubMed
46.
go back to reference MacGregor CA, Canney PA, Patterson G, McDonald R, Paul J: A randomised double-blind controlled trial of oral soy supplements versus placebo for treatment of menopausal symptoms in patients with early breast cancer. Eur J Cancer. 2005, 41: 708-714. 10.1016/j.ejca.2005.01.005.CrossRefPubMed MacGregor CA, Canney PA, Patterson G, McDonald R, Paul J: A randomised double-blind controlled trial of oral soy supplements versus placebo for treatment of menopausal symptoms in patients with early breast cancer. Eur J Cancer. 2005, 41: 708-714. 10.1016/j.ejca.2005.01.005.CrossRefPubMed
47.
go back to reference Van Patten CL, Olivotto IA, Chambers GK, Gelmon KA, Hislop TG, Templeton E, Wattie A, Prior JC: Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial. J Clin Oncol. 2002, 20: 1449-1455. 10.1200/JCO.20.6.1449.CrossRefPubMed Van Patten CL, Olivotto IA, Chambers GK, Gelmon KA, Hislop TG, Templeton E, Wattie A, Prior JC: Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial. J Clin Oncol. 2002, 20: 1449-1455. 10.1200/JCO.20.6.1449.CrossRefPubMed
48.
go back to reference Upmalis DH, Lobo R, Bradley L, Warren M, Cone FL, Lamia CA: Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study. Menopause. 2000, 7: 236-242. 10.1097/00042192-200007040-00005.CrossRefPubMed Upmalis DH, Lobo R, Bradley L, Warren M, Cone FL, Lamia CA: Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study. Menopause. 2000, 7: 236-242. 10.1097/00042192-200007040-00005.CrossRefPubMed
49.
go back to reference Chan RY, Chen WF, Dong A, Guo D, Wong MS: Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng. J Clin Endocrinol Metab. 2002, 87: 3691-3695. 10.1210/jc.87.8.3691.CrossRefPubMed Chan RY, Chen WF, Dong A, Guo D, Wong MS: Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng. J Clin Endocrinol Metab. 2002, 87: 3691-3695. 10.1210/jc.87.8.3691.CrossRefPubMed
50.
go back to reference Cho J, Park W, Lee S, Ahn W, Lee Y: Ginsenoside-Rb1 from Panax ginseng C.A. Meyer activates estrogen receptor-alpha and -beta, independent of ligand binding. J Clin Endocrinol Metab. 2004, 89: 3510-3515. 10.1210/jc.2003-031823.CrossRefPubMed Cho J, Park W, Lee S, Ahn W, Lee Y: Ginsenoside-Rb1 from Panax ginseng C.A. Meyer activates estrogen receptor-alpha and -beta, independent of ligand binding. J Clin Endocrinol Metab. 2004, 89: 3510-3515. 10.1210/jc.2003-031823.CrossRefPubMed
51.
go back to reference Wiklund IK, Mattsson LA, Lindgren R, Limoni C: Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. Swedish Alternative Medicine Group. Int J Clin Pharmacol Res. 1999, 19: 89-99.PubMed Wiklund IK, Mattsson LA, Lindgren R, Limoni C: Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. Swedish Alternative Medicine Group. Int J Clin Pharmacol Res. 1999, 19: 89-99.PubMed
52.
go back to reference Cui Y, Shu XO, Gao YT, Cai H, Tao MH, Zheng W: Association of ginseng use with survival and quality of life among breast cancer patients. Am J Epidemiol. 2006, 163: 645-653. 10.1093/aje/kwj087.CrossRefPubMed Cui Y, Shu XO, Gao YT, Cai H, Tao MH, Zheng W: Association of ginseng use with survival and quality of life among breast cancer patients. Am J Epidemiol. 2006, 163: 645-653. 10.1093/aje/kwj087.CrossRefPubMed
53.
go back to reference Coon JT, Ernst E: Panax ginseng: a systematic review of adverse effects and drug interactions. Drug Saf. 2002, 25: 323-344. 10.2165/00002018-200225050-00003.CrossRefPubMed Coon JT, Ernst E: Panax ginseng: a systematic review of adverse effects and drug interactions. Drug Saf. 2002, 25: 323-344. 10.2165/00002018-200225050-00003.CrossRefPubMed
56.
go back to reference Axelson M, Sjovall J, Gustafsson BE, Setchell KD: Origin of lignans in mammals and identification of a precursor from plants. Nature. 1982, 298: 659-660. 10.1038/298659a0.CrossRefPubMed Axelson M, Sjovall J, Gustafsson BE, Setchell KD: Origin of lignans in mammals and identification of a precursor from plants. Nature. 1982, 298: 659-660. 10.1038/298659a0.CrossRefPubMed
57.
go back to reference Johnston P: Flaxseed oil and cancer: a-linolenic acid and carcinogenesis. Flaxseed in Human Nutrition. 1995, Champaign, IL: AOCS Press, Champaign Johnston P: Flaxseed oil and cancer: a-linolenic acid and carcinogenesis. Flaxseed in Human Nutrition. 1995, Champaign, IL: AOCS Press, Champaign
58.
go back to reference Borriello SP, Setchell KD, Axelson M, Lawson AM: Production and metabolism of lignans by the human faecal flora. J Appl Bacteriol. 1985, 58: 37-43. 10.1111/j.1365-2672.1985.tb01427.x.CrossRefPubMed Borriello SP, Setchell KD, Axelson M, Lawson AM: Production and metabolism of lignans by the human faecal flora. J Appl Bacteriol. 1985, 58: 37-43. 10.1111/j.1365-2672.1985.tb01427.x.CrossRefPubMed
59.
go back to reference Kim JY, Park HD, Park E, Chon JW, Park YK: Growth-inhibitory and proapoptotic effects of alpha-linolenic acid on estrogen-positive breast cancer cells. Ann N Y Acad Sci. 2009, 1171: 190-195. 10.1111/j.1749-6632.2009.04897.x.CrossRefPubMed Kim JY, Park HD, Park E, Chon JW, Park YK: Growth-inhibitory and proapoptotic effects of alpha-linolenic acid on estrogen-positive breast cancer cells. Ann N Y Acad Sci. 2009, 1171: 190-195. 10.1111/j.1749-6632.2009.04897.x.CrossRefPubMed
60.
go back to reference Serraino M, Thompson LU: The effect of flaxseed supplementation on the initiation and promotional stages of mammary tumorigenesis. Nutr Cancer. 1992, 17: 153-159. 10.1080/01635589209514182.CrossRefPubMed Serraino M, Thompson LU: The effect of flaxseed supplementation on the initiation and promotional stages of mammary tumorigenesis. Nutr Cancer. 1992, 17: 153-159. 10.1080/01635589209514182.CrossRefPubMed
61.
go back to reference Thompson LU, Rickard SE, Orcheson LJ, Seidl MM: Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis. Carcinogenesis. 1996, 17: 1373-1376. 10.1093/carcin/17.6.1373.CrossRefPubMed Thompson LU, Rickard SE, Orcheson LJ, Seidl MM: Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis. Carcinogenesis. 1996, 17: 1373-1376. 10.1093/carcin/17.6.1373.CrossRefPubMed
62.
go back to reference Stoll AL, Locke CA, Marangell LB, Severus WE: Omega-3 fatty acids and bipolar disorder: a review. Prostaglandins Leukot Essent Fatty Acids. 1999, 60: 329-337. 10.1016/S0952-3278(99)80008-8.CrossRefPubMed Stoll AL, Locke CA, Marangell LB, Severus WE: Omega-3 fatty acids and bipolar disorder: a review. Prostaglandins Leukot Essent Fatty Acids. 1999, 60: 329-337. 10.1016/S0952-3278(99)80008-8.CrossRefPubMed
63.
go back to reference Spence JD, Thornton T, Muir AD, Westcott ND: The effect of flax seed cultivars with differing content of alpha-linolenic acid and lignans on responses to mental stress. J Am Coll Nutr. 2003, 22: 494-501.CrossRefPubMed Spence JD, Thornton T, Muir AD, Westcott ND: The effect of flax seed cultivars with differing content of alpha-linolenic acid and lignans on responses to mental stress. J Am Coll Nutr. 2003, 22: 494-501.CrossRefPubMed
64.
go back to reference Tice JA, Ettinger B, Ensrud K, Wallace R, Blackwell T, Cummings SR: Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial. Jama. 2003, 290: 207-214. 10.1001/jama.290.2.207.CrossRefPubMed Tice JA, Ettinger B, Ensrud K, Wallace R, Blackwell T, Cummings SR: Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial. Jama. 2003, 290: 207-214. 10.1001/jama.290.2.207.CrossRefPubMed
65.
go back to reference Saloniemi H, Wahala K, Nykanen-Kurki P, Kallela K, Saastamoinen I: Phytoestrogen content and estrogenic effect of legume fodder. Proc Soc Exp Biol Med. 1995, 208: 13-17.CrossRefPubMed Saloniemi H, Wahala K, Nykanen-Kurki P, Kallela K, Saastamoinen I: Phytoestrogen content and estrogenic effect of legume fodder. Proc Soc Exp Biol Med. 1995, 208: 13-17.CrossRefPubMed
66.
go back to reference Boue SM, Wiese TE, Nehls S, Burow ME, Elliott S, Carter-Wientjes CH, Shih BY, McLachlan JA, Cleveland TE: Evaluation of the estrogenic effects of legume extracts containing phytoestrogens. J Agric Food Chem. 2003, 51: 2193-2199. 10.1021/jf021114s.CrossRefPubMed Boue SM, Wiese TE, Nehls S, Burow ME, Elliott S, Carter-Wientjes CH, Shih BY, McLachlan JA, Cleveland TE: Evaluation of the estrogenic effects of legume extracts containing phytoestrogens. J Agric Food Chem. 2003, 51: 2193-2199. 10.1021/jf021114s.CrossRefPubMed
67.
go back to reference Hwang J, Hodis HN, Sevanian A: Soy and alfalfa phytoestrogen extracts become potent low-density lipoprotein antioxidants in the presence of acerola cherry extract. J Agric Food Chem. 2001, 49: 308-314. 10.1021/jf0007028.CrossRefPubMed Hwang J, Hodis HN, Sevanian A: Soy and alfalfa phytoestrogen extracts become potent low-density lipoprotein antioxidants in the presence of acerola cherry extract. J Agric Food Chem. 2001, 49: 308-314. 10.1021/jf0007028.CrossRefPubMed
68.
go back to reference Dixit VP, Joshi SC: Antiatherosclerotic effects of alfalfa meal ingestion in chicks: a biochemical evaluation. Indian J Physiol Pharmacol. 1985, 29: 47-50.PubMed Dixit VP, Joshi SC: Antiatherosclerotic effects of alfalfa meal ingestion in chicks: a biochemical evaluation. Indian J Physiol Pharmacol. 1985, 29: 47-50.PubMed
69.
go back to reference De Leo V, Lanzetta D, Cazzavacca R, Morgante G: Treatment of neurovegetative menopausal symptoms with a phytotherapeutic agent. Minerva Ginecol. 1998, 50: 207-211.PubMed De Leo V, Lanzetta D, Cazzavacca R, Morgante G: Treatment of neurovegetative menopausal symptoms with a phytotherapeutic agent. Minerva Ginecol. 1998, 50: 207-211.PubMed
70.
go back to reference Labrie F: DHEA, important source of sex steroids in men and even more in women. Prog Brain Res. 2010, 182: 97-148.CrossRefPubMed Labrie F: DHEA, important source of sex steroids in men and even more in women. Prog Brain Res. 2010, 182: 97-148.CrossRefPubMed
71.
go back to reference Barton DL, Loprinzi C, Atherton PJ, Kottschade L, Collins M, Carpenter P, Adjei A, Rummans TA, Shanafelt T, Christensen B, Sloan J: Dehydroepiandrosterone for the treatment of hot flashes: a pilot study. Support Cancer Ther. 2006, 3: 91-97. 10.3816/SCT.2006.n.004.CrossRefPubMed Barton DL, Loprinzi C, Atherton PJ, Kottschade L, Collins M, Carpenter P, Adjei A, Rummans TA, Shanafelt T, Christensen B, Sloan J: Dehydroepiandrosterone for the treatment of hot flashes: a pilot study. Support Cancer Ther. 2006, 3: 91-97. 10.3816/SCT.2006.n.004.CrossRefPubMed
Metadata
Title
Estrogenic botanical supplements, health-related quality of life, fatigue, and hormone-related symptoms in breast cancer survivors: a HEAL study report
Authors
Huiyan Ma
Jane Sullivan-Halley
Ashley W Smith
Marian L Neuhouser
Catherine M Alfano
Kathleen Meeske
Stephanie M George
Anne McTiernan
Roberta McKean-Cowdin
Kathy B Baumgartner
Rachel Ballard-Barbash
Leslie Bernstein
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2011
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/1472-6882-11-109

Other articles of this Issue 1/2011

BMC Complementary Medicine and Therapies 1/2011 Go to the issue